Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.19−0.02 (-10.00%)
Close on Nov 18, 2026Market cap $852.76KP/E –Yield –
Oragenics net income
Net income is the profit left for shareholders after every expense, interest and tax.
Oragenics's net income for the twelve months ending Jun 30, 2026 was -$10.08M. For fiscal 2025 it was -$9.84M. The highest annual figure on record is -$5.79M in fiscal 2014.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.84M | – |
| FY2024 | Dec 31, 2024 | -$10.57M | – |
| FY2023 | Dec 31, 2023 | -$20.66M | – |
| FY2022 | Dec 31, 2022 | -$14.29M | – |
| FY2021 | Dec 31, 2021 | -$15.71M | – |
| FY2020 | Dec 31, 2020 | -$26.43M | – |
| FY2019 | Dec 31, 2019 | -$15.57M | – |
| FY2018 | Dec 31, 2018 | -$9.91M | – |
| FY2017 | Dec 31, 2017 | -$6.73M | – |
| FY2016 | Dec 31, 2016 | -$7.01M | – |
| FY2015 | Dec 31, 2015 | -$11.71M | – |
| FY2014 | Dec 31, 2014 | -$5.79M | – |
| FY2013 | Dec 31, 2013 | -$16.07M | – |
| FY2012 | Dec 31, 2012 | -$13.09M | – |
| FY2011 | Dec 31, 2011 | -$7.68M | – |
| FY2010 | Dec 31, 2010 | -$7.81M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.53M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.29M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.07M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.27M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.22M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.35M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.31M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.45M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.75M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.01M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.05M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.84M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.24M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.87M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.59M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.59M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.29M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.38M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.82M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.22M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.41M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.50M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.34M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.19M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.60M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.84M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.81M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.33M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.76M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.28M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.12M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.46M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.07M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.22M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.98M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.67M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.96M | – |
See a number that looks wrong?